-- Days : -- HRS : -- MIN : -- SEC

Register Now →

News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Jamie M. Terrell, PharmD

Articles by Jamie M. Terrell, PharmD

Incretin Mimetics: Pros and Cons, and Emerging Agents in Diabetes Treatment

ByJamie M. Terrell, PharmD,Tibb F. Jacobs, PharmD, BCPS

December 14th 2013

Drug Pipeline

Latest Updated Articles

Incretin Mimetics: Pros and Cons, and Emerging Agents in Diabetes Treatment
December 14th 2013

Trending on AJMC

FDA Approves Lutetium Lu 177 for Earlier-Stage Prostate Cancer

FDA Panel Backs 6 Peptides for Compounding

Atacicept Becomes First BAFF/APRIL Inhibitor Approved for IgA Nephropathy: Richard Lafayette, MD

Boston Panel Confronts Access and Coordination Gaps in Obesity Care

Pediatric Chronic Skin Disorders Linked to Poorer Mental Health